drugset / Trial / NCT00002202
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
Treatment
Summary
The purpose of this study is to see if 141W94 is as safe and effective as indinavir when used with nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. This study also examines what effect other drugs have on how the body handles 141W94.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | — | — |
| Background | Amprenavir | Other / unclassified | — | — |